EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeted Liposomal Drug Delivery: Overview of the Current Applications and Challenges

Matthew S Gatto, McNeely P Johnson, Wided Najahi-Missaoui

Life · 24.05.2024 · 14 (6) · 672

DOI: 10.3390/life14060672 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 24.05.2024. Verfasst von Matthew S Gatto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602, USA. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In drug development, it is not uncommon that an active substance exhibits efficacy in vitro but lacks the ability to specifically reach its target in vivo. As a result, targeted drug delivery has become a primary focus in the pharmaceutical sciences. Since the approval of Doxil® in 1995, liposomes have emerged as a leading nanoparticle in targeted drug delivery. Their low immunogenicity, high versatility, and well-documented efficacy have led to their clinical use against a wide variety of diseases. That being said, every disease is accompanied by a unique set of physiological conditions, and each liposomal product must be formulated with this consideration. There are a multitude of different targeting techniques for liposomes that can be employed depending on the application. Passive techniques such as PEGylation or the enhanced permeation and retention effect can improve general pharmacokinetics, while active techniques such as conjugating targeting molecules to the liposome surface may bring even further specificity. This review aims to summarize the current strategies for targeted liposomes in the treatment of diseases.

Schlagwörter

Stichwörter der Autor:innen

EPRPEGylationactive targetingdrug deliveryliposomesnanoparticlespassive targetingtargeted therapy

Autor:innen und Institutionen

  • Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602, USA.

Zitieren

APA

Gatto, M. S., Johnson, M. P., & Najahi-Missaoui, W. (2024). Targeted Liposomal Drug Delivery: Overview of the Current Applications and Challenges. Life, 14(6), 672. https://doi.org/10.3390/life14060672

Vancouver

Gatto MS, Johnson MP, Najahi-Missaoui W. Targeted Liposomal Drug Delivery: Overview of the Current Applications and Challenges. Life. 2024;14(6):672. doi:10.3390/life14060672

BibTeX
@article{Gatto2024,
  author = {Gatto, Matthew S and Johnson, McNeely P and Najahi-Missaoui, Wided},
  title = {Targeted Liposomal Drug Delivery: Overview of the Current Applications and Challenges},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {6},
  pages = {672},
  doi = {10.3390/life14060672}
}
Kostenlos starten →